Patents for C07D 521 - Heterocyclic compounds containing unspecified hetero rings (16,203) |
---|
03/08/2011 | CA2487532C Pyrrolidine derivatives as oxytocin antagonists |
03/08/2011 | CA2446756C Thiazole compounds useful as inhibitors of protein kinase |
03/02/2011 | CN1769251B Oligonaphthalene derivatives, and light-emitting element and light-emitting device using oligonaphthalene derivatives |
02/23/2011 | EP1409461B1 Novel azole or triazole derivatives, method for preparing same and use thereof as fungicides |
02/23/2011 | CN101979394A A method to inhibit ethylene responses in plants |
02/17/2011 | US20110039802 Npy y5 antagonist |
02/16/2011 | EP1379498B1 Sulphones which modulate the action of gamma secretase |
02/09/2011 | CN101967146A Ep4 receptor inhibitors to treat rheumatoid arthritis |
02/08/2011 | CA2446924C 2-iminopyrrolidine derivatives |
02/02/2011 | EP1020179B9 Peptide derivatives or pharmaceutically acceptable salts thereof, method for producing the same, use of said derivatives and pharmaceutical composition |
02/01/2011 | US7879995 organic electroluminescent device has, between a pair of electrodes, at least one organic layer including a light-emitting layer, in which the organic layer contains a specific tetraphenylene compound |
02/01/2011 | CA2315717C Inhibition of raf kinase using substituted heterocyclic ureas |
01/26/2011 | EP2277879A1 Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist |
01/25/2011 | CA2494323C Amino benzothiazole compounds with nos inhibitory activity |
01/25/2011 | CA2404125C Sulphonamido-substituted bridged bicycloalkyl derivatives |
01/20/2011 | US20110015360 Dithiocarbamic esters |
01/19/2011 | EP2275395A2 Copper-catalyzed formation of carbon-carbon bonds |
01/18/2011 | CA2416874C 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists |
01/12/2011 | EP2272813A2 Copper-catalyzed formation of carbon-oxygen bonds |
01/12/2011 | CN101945872A (1-azinone) -substituted pyridoindoles as mch antagonists |
01/11/2011 | US7868204 Inhibitors of histone deacetylase |
01/11/2011 | CA2385592C Benzamides and related inhibitors of factor xa |
01/04/2011 | CA2458533C Imidazole derivates as anti-inflammatory agents |
01/04/2011 | CA2454703C Novel thiophene carboxamide derivatives |
12/29/2010 | EP2266986A1 Cytotoxins, Prodrugs, Linkers and Stabilizers useful therefor |
12/28/2010 | US7858802 Method of preparing ionic liquids |
12/22/2010 | EP2264028A1 Pyrazole compounds useful as protein kinase inhibitors |
12/21/2010 | US7855297 Amide derivatives and medicinal use thereof |
12/21/2010 | CA2401778C Benzamides and related inhibitors of factor xa |
12/14/2010 | CA2391274C Method for detecting pathogenic microorganism and antimicrobial agent, method for evaluating effect of antimicrobial agent, and antimicrobial agent |
12/08/2010 | EP2258694A1 Amines as histamine-3 receptor ligands and their therapeutic applications |
12/07/2010 | US7847101 such as (4-Benzothiazol-2-yl-1H-pyrazol-3-yl)-[2-(1H-imidazol-4-yl)-ethyl]-amine, used in the treatment of disorders associated with hyperproliferation and tissue remodelling or repair, inflammation, cell migration and invasion, and renal diseases, or as protein kinase inhibitors |
12/01/2010 | CN101899039A Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist |
12/01/2010 | CN101898982A Npy y5 antagonists |
11/30/2010 | CA2144474C Substituted n-ethylglycine derivatives for preparing pna and pna/dna hybrids |
11/25/2010 | US20100298284 Benzamides and related inhibitors of factor xa |
11/24/2010 | EP2253620A1 Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors |
11/24/2010 | EP2253328A1 Cycloalkyl inhibitors of potassium channel function |
11/24/2010 | EP1233936B2 Process for preparing ambient temperature ionic liquids |
11/23/2010 | US7838520 Inhibitors of histone deacetylase |
11/23/2010 | CA2404755C Imidazole carbenes |
11/18/2010 | US20100292500 Npy y5 antagonist |
11/16/2010 | CA2404680C Synthesis procedure for biphenylimidazolyl-(1)-phenylmethane and related compounds |
11/11/2010 | US20100286197 Carboxamide Derivatives As Therapeutic Agents |
11/11/2010 | US20100285963 Substituted fluoroalkoxyphenylsulfonylureas |
11/04/2010 | US20100280042 Quinazoline derivatives for the treatment of tumours |
11/03/2010 | EP1496838B1 Substituted amides |
11/02/2010 | US7825193 Dithiocarbamic esters |
11/02/2010 | US7825124 Indolylmaleimide derivatives |
11/02/2010 | CA2389681C Npy y5 antagonist |
10/26/2010 | CA2293436C Imidazolyl-cyclic acetals as tnf inhibitors |
10/26/2010 | CA2192928C Benzoheterocyclic derivatives |
10/21/2010 | US20100267609 Compounds which inhibit beta-secretase activity and methods of use thereof |
10/20/2010 | EP2240481A1 (1-azinone) -substituted pyridoindoles as mch antagonists |
10/20/2010 | EP1283832B1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
10/19/2010 | US7816534 N-[3-(4-chlorophenyl)-2-(3-pyridyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists |
10/19/2010 | CA2362715C Quinazoline derivatives as angiogenesis inhibitors |
10/12/2010 | CA2455863C Tetrahydroquinoline derivatives as gamma secretase inhibitors |
10/07/2010 | US20100256201 Cell differentiation inducer |
10/07/2010 | US20100256170 Pyrazole compounds useful as protein kinase inhibitors |
10/06/2010 | CN101851173A Inhibitors of histone deacetylase |
10/05/2010 | US7807694 Amine substituted (dihydro- or tetrahydro-)quinoline, pyranopyridine, thiapyranopyridine, or naphthyridine derivatives as chemokine receptor modulators; lymphadenopathy associated, human T-cell leukemia/lymphoma, and/or feline immunodeficiency virus infections |
10/05/2010 | CA2400479C Platelet adp receptor inhibitors |
09/29/2010 | EP1421074B1 Novel compounds |
09/29/2010 | EP1399402B1 Intermediate halophenyl derivatives and their use in a process for preparing azole derivatives |
09/22/2010 | EP2229935A1 Peptide derivatives or pharmaceutically acceptable salts thereof, method for producing the same, use of said derivatives and pharmaceutical composition |
09/22/2010 | EP1599464B1 Novel cyclic urea derivatives, preparation method thereof and pharmaceutical use of same as kinase inhibitors |
09/21/2010 | US7799827 zearalenone-like macrolides, used to to inhibit nuclear factor kappa-beta (NF- kappa B) activation, as sucnscreen agents and in the treatment of inflammatory or autoimmune disorders and disorders involving malignancy or increased angiogenesis |
09/16/2010 | US20100234350 Platelet adp receptor inhibitors |
09/15/2010 | EP2228065A2 Heterocyclo inhibitors of potassium channel function |
09/15/2010 | EP2027132B1 Thiazolo-pyramidine / pyridine urea derivatives as adenosine a2b receptor antagonists |
09/15/2010 | CN101830889A 嘧啶衍生物 Pyrimidine derivatives |
09/14/2010 | CA2422805C Retinoids for the treatment of emphysema |
09/08/2010 | EP1841741B1 Piperidine derivatives as prodrugs of potassium channel inhibitors |
09/08/2010 | CN1798746B Reverse-turn mimetics and method relating thereto |
09/07/2010 | US7790902 tyrosine kinase inhibitors such as 5-(3,3-Dimethyl-ureido)-3-heptyloxy-isothiazole-4-carboxylic acid amide, used for treating hyperproliferative disorders in mammals; anticarcinogenic agents; antiproliferative agents |
09/07/2010 | US7790719 used for the treatment of cachexia and other weight loss disorders, such as those resulting from cancer, HIV, old age and anorexia nervosa |
08/31/2010 | US7786161 prostaglandin receptor antagonists such as 2-(2-((4-methyl-2-(naphthalen-1-yl)pentanoyl)amino)-4-(pyrazol-1-ylmethyl) benzyl)benzoic acid, used for the prevention and/or treatment of diseases induced pain, skin disorders, allergies, urogenital disorders, Alzheimer's disease, cancer and dysmenorrhea |
08/31/2010 | US7786156 reacting [2-(5-Hydrazinomethyl-1H-indol-3-yl)-ethyl]-dimethyl-amine with a 1,2,4-triazolyl forming reagent such as 1,3,5-triazine, formamidine, formamidinium salts or formamide, to obtain (3-[2-(dimethylamino)ethyl]-5-(1,2,4-triazol-1-ylmethyl)indole) |
08/31/2010 | US7786131 Anticancer agents; restenosis; atherosclerosis; skin disorders |
08/31/2010 | US7786123 Indolylmaleimide derivatives |
08/31/2010 | US7786122 use to treat Alzheimer's Disease; (2R)-2-[N-(4-Chlorobenzenesulfonyl)-N-(4-methoxybenzyl)amino]-4-methylpentanoic acid amide for example |
08/24/2010 | US7781596 Substituted 2-phenylbenzimidazoles, the production thereof and their use |
08/24/2010 | US7781461 Neuropeptide Y receptor antagonists comprising 4-(tert-butylsulfonylamino)-N-[5-(trifluoromethyl)pyridin-2-yl]cyclohexane-1-carboxamide and a pharmaceutically acceptable carrier, used for the treatment of obesity and as anorexigenic agents |
08/17/2010 | US7776919 modulators of the interaction between the receptor for advanced glycated end products; 3-(4-Benzyloxyphenyl)propionic Acid 2,4- Di-(3-Diethylamino-1-propoxy)aniline Amide; acute and chronic inflammation; diabetic late complications; Alzheimer's disease, erectile dysfunction; metastasis |
08/17/2010 | CA2438991C Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
08/11/2010 | EP1537099B1 Pyrrole based inhibitors of glycogen synthase kinase 3 |
08/11/2010 | CN101798298A Imidazole derivatives |
08/10/2010 | US7772252 Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands |
08/10/2010 | US7772224 Calcitonin gene-related peptide (CGRP) receptor antagonists such as N-[1-(2,3-Difluorobenzyl)-5-oxo-4-(2,22-trifluoroethyl)-1,4-diazepan-6-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide, used for treating headaches |
08/05/2010 | US20100197736 Cetp activity inhibitors |
07/27/2010 | CA2448319C Cytotoxins, prodrugs, linkers and stabilizers useful therefor |
07/20/2010 | CA2290136C New erythromycin derivatives, the process for preparing them and their use as a drug product |
07/13/2010 | US7754053 Distillation of ionic liquids |
07/13/2010 | CA2409697C Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
07/06/2010 | US7750151 Inhibitors of Akt activity |
06/30/2010 | EP1495035B1 Method for the production of bis(perfluoroalkyl)phosphinic acids and the salts thereof |
06/30/2010 | EP1278735B1 2,4-di(hetero-)arylamino(-oxy)-5-substituted pyrimidines as antineoplastic agents |
06/29/2010 | US7745472 Dimethylsulfamic Acid 2-bromo-4-{[(4-cyano-phenyl)-[1,2,4]triazol-4-ylamino]methyl}phenyl Ester, used as effective sulfatase and/or aromatase inhibitors, and as modulators of cell cycling and modulators of apoptosis; therapy of breast, prostate, ovarian or endometrial cancer |
06/29/2010 | CA2442885C Sulphones which modulate the action of gamma secretase |